MediPharm Labs Corp.
LABS.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.59M | -6.32M | -5.96M | -5.78M | -6.26M |
| Total Depreciation and Amortization | 1.13M | 1.17M | 1.19M | 1.30M | 1.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 782.10K | 747.80K | 805.50K | 90.30K | 474.40K |
| Change in Net Operating Assets | 970.50K | 2.00M | 65.20K | -589.20K | -940.20K |
| Cash from Operations | -700.80K | -2.40M | -3.90M | -4.98M | -5.35M |
| Capital Expenditure | -44.70K | -42.70K | -71.30K | -102.70K | -115.30K |
| Sale of Property, Plant, and Equipment | 344.90K | 3.41M | 3.41M | 3.41M | 3.07M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 300.20K | 3.37M | 3.34M | 3.31M | 2.95M |
| Total Debt Issued | 457.00K | 500.00K | 500.00K | 500.00K | 550.00K |
| Total Debt Repaid | -581.00K | -611.00K | -692.00K | -806.00K | -2.98M |
| Issuance of Common Stock | -- | -- | -- | 14.00K | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 171.00K | 164.00K | 174.00K | 213.00K | 186.00K |
| Cash from Financing | 27.00K | 39.60K | -6.80K | -49.80K | -1.63M |
| Foreign Exchange rate Adjustments | 6.80K | 18.10K | 12.70K | 600.00 | 18.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -366.80K | 1.03M | -555.00K | -1.72M | -4.00M |